USPTO serial 86870151
ALINIQ ACTIVE SENSE
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- —
- Examiner
- CIANCI, RYAN MICHAEL
- Law office
- TMO LAW OFFICE 116 - EXAMINING ATTORNEY ASSIGNED
What this means
These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.
Need help with ALINIQ ACTIVE SENSE?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele H. Bowman
Michele H. Bowman ABBOTT LABORATORIES100 Abbott Park RoadAbbott Park, IL 60064UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Consulting services in the field of laboratory testing; consulting services in the field of medical diagnostics; consulting regarding the quality control of laboratory instruments for the purpose of gathering operational data and testing data; consulting regarding the quality of medical diagnostic instruments for the purpose of gathering operational data and testing data; consulting regarding medical diagnostic software; consulting regarding medical software; consulting regarding software in the field of health; installation, maintenance and repair of software and hardware related to medical diagnostic instruments; providing technical support, namely, troubleshooting regarding laboratory software in the field of medical diagnostics; remote electronic operational monitoring of diagnostic laboratory systems, laboratory automation systems, and medical diagnostic instruments; providing platform as a service (PAAS) featuring a web-based software platform for laboratory and medical diagnostic information management; platform as a service (PAAS) featuring providing a web-based software platform in the field of health, for monitoring laboratory operations; platform as a service (PAAS) featuring providing a web-based software platform in the field of medical diagnostics, for analyzing bodily fluid and tissue samples; software as a service (SAAS) services featuring software for laboratory and diagnostic equipment information management, monitoring and analysis in the field of medical diagnostics; software as a service (SAAS) featuring software for laboratory and diagnostic equipment information management, monitoring and analysis services in the field of health; platform as a service (PAAS) in the field of health, featuring software platforms for laboratory and diagnostic equipment information management, monitoring and analysis in the field of in vitro diagnostics; conducting medical diagnostic testing facility evaluations to assess, quality, environmental sustainability, waste, efficiency, operational downtime, flexibility and agility, namely, quality management evaluations of the medical diagnostic facilities of others to assess steps required to attain optimal efficiency; conducting laboratory, healthcare facility and healthcare system operational research and analyzing and reporting regarding laboratory, healthcare facility and healthcare system operational performance, namely, research, analysis and reporting regarding the performance and efficiency of laboratory instruments, medical diagnostic instruments, accompanying computer systems, workflow structure and workflow management and personnel task workflow and completion; conducting operational research, monitoring and analysis regarding medical diagnostic instruments, tests and assays, namely, evaluations of the quality and performance of medical diagnostic instruments, tests and assays; analyzing and reporting operational research data, namely, compiling, analyzing and reporting information regarding the performance of medical diagnostic instruments, tests and assays; monitoring, analyzing and reporting services, namely, quality control in the field of medical laboratory equipment operations, medical laboratory inventory management, medical laboratory quality management; data and information management, tracking, analyzing and reporting in the field of medical diagnostics, namely, tracking, analyzing and reporting of performance data for medical diagnostic equipment using computers and sensors | ACTIVE | Mar 31, 2016 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Dec 7, 2020 | MAB0 | ABANDONMENT NOTICE MAILED - INCOMPLETE RESPONSE | — |
| Dec 7, 2020 | ABN0 | ABANDONMENT - INCOMPLETE RESPONSE | — |
| Nov 19, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 19, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 12, 2020 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| May 18, 2020 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| May 18, 2020 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| May 18, 2020 | CNFR | SU - FINAL REFUSAL - WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 21, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Apr 21, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Apr 21, 2020 | ALIE | ASSIGNED TO LIE | — |
| Apr 16, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Oct 16, 2019 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2019 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 16, 2019 | CNRT | SU - NON-FINAL ACTION - WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 8, 2019 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Oct 8, 2019 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Sep 19, 2019 | IUAF | USE AMENDMENT FILED | — |
| Sep 19, 2019 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 21, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 19, 2019 | EX3G | SOU EXTENSION 3 GRANTED | — |
| Mar 19, 2019 | EXT3 | SOU EXTENSION 3 FILED | — |
| Mar 19, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 20, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 18, 2018 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Sep 18, 2018 | EXT2 | SOU EXTENSION 2 FILED | — |
| Sep 18, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 20, 2018 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 16, 2018 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Mar 16, 2018 | EXT1 | SOU EXTENSION 1 FILED | — |
| Mar 16, 2018 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 19, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jul 25, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jul 25, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jul 5, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Jun 14, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| May 27, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 26, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 26, 2017 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Nov 29, 2016 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Nov 29, 2016 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 29, 2016 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 8, 2016 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 7, 2016 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 7, 2016 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| May 9, 2016 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| May 6, 2016 | ALIE | ASSIGNED TO LIE | — |
| May 6, 2016 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 6, 2016 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| May 6, 2016 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Apr 25, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 15, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 12, 2016 | NWAP | NEW APPLICATION ENTERED | — |